Updates
Stay informed on recent developments in the world of biomarkers for bladder cancer surveillance
Exploring the benefits of urinary biomarkers in NMIBC surveillance
Watch the interviews with expert urologists Dr. Félix Guerrero-Ramos and Prof. Dr. Fred Witjes sharing their clinical experiences about alternating cystoscopies with urinary biomarkers in the follow-up schedule of patients with non-muscle-invasive bladder cancer...
The diagnostic value of urinary biomarkers in UTUC
Reviewed by Mr. Hugh Mostafid (Royal Surrey County Hospital, Guildford, UK) UTUC: similarities and differences compared to bladder cancer While bladder tumours account for 90-95% of all urothelial carcinomas (UCa), only 5-10% of UCa cases involve the upper urinary...
Including Bladder EpiCheck® in NMIBC surveillance leads to a major reduction in healthcare costs
Urinary biomarker tests, including Bladder EpiCheck®, are reimbursed from January 2024 in the Netherlands Reviewed by Prof. Joost Boormans (Erasmus MC Cancer Institute, Rotterdam, The Netherlands) Pitfalls of the current standard for NMIBC follow-up Due to the high...
Henry with intermediate-risk NMIBC finds follow-up cystoscopies burdensome. What now?
Henry, 70 years old, used to work as a creative director in a chocolate factory. Once, he designed chocolates that looked like broccoli. Too bad, they were not favoured by the clients … He was initially diagnosed with a solitary small Ta low-grade (LG) tumour. He...
May is bladder cancer awareness month
The World Bladder Cancer Patient Coalition hosts this special month to raise awareness of the disease. The theme of this year’s edition “Feeling unsure? Get checked.” is to bring attention to the misrepresentation of symptoms and to encourage people to re-evaluate...
Compare your opinion with peers and Prof. Dr. Morgan Rouprêt
Miranda, 81 years old, resides in a retirement home. To fill her day, she knits woollen scarves and hats for her fellow residents. Two years ago, she underwent TURBT of 1 small papillary tumour of 1 cm at the right bladder wall, which was detected during a cystoscopic...
Exploring the benefits of urinary biomarkers in NMIBC surveillance
Watch the interviews with expert urologists Dr. Félix Guerrero-Ramos and Prof. Dr. Fred Witjes sharing their clinical experiences about alternating cystoscopies with urinary biomarkers in the follow-up schedule of patients with non-muscle-invasive bladder cancer...
The diagnostic value of urinary biomarkers in UTUC
Reviewed by Mr. Hugh Mostafid (Royal Surrey County Hospital, Guildford, UK) UTUC: similarities and differences compared to bladder cancer While bladder tumours account for 90-95% of all urothelial carcinomas (UCa), only 5-10% of UCa cases involve the upper urinary...
Including Bladder EpiCheck® in NMIBC surveillance leads to a major reduction in healthcare costs
Urinary biomarker tests, including Bladder EpiCheck®, are reimbursed from January 2024 in the Netherlands Reviewed by Prof. Joost Boormans (Erasmus MC Cancer Institute, Rotterdam, The Netherlands) Pitfalls of the current standard for NMIBC follow-up Due to the high...
Henry with intermediate-risk NMIBC finds follow-up cystoscopies burdensome. What now?
Henry, 70 years old, used to work as a creative director in a chocolate factory. Once, he designed chocolates that looked like broccoli. Too bad, they were not favoured by the clients … He was initially diagnosed with a solitary small Ta low-grade (LG) tumour. He...